Q-Line Biotec IPO Day 3 Subscription Status: Subscribed 102.14x Overall
By HDFC SKY | Published at: May 25, 2026 05:14 PM IST
Q-Line Biotec IPO subscribed 102.14 times on Day 3, led by NII and QIB demand.
Mumbai, May 25: Q-Line Biotec IPO is a book-built issue of ₹214.48 crore. The issue is entirely a fresh issue of 62,53,200 equity shares.
The IPO opened for subscription on May 21, 2026, and closes today. The price band is fixed at ₹326 to ₹343 per share. The lot size is 400 shares.
Q-Line Biotec IPO Day 3 Subscription Status
Q-Line Biotec IPO was subscribed 102.14 times on Day 3 as of May 25, 2026, 4:30 PM.
| Particulars | Details |
| Total Subscription | 102.14x |
| Issue Size | ₹214.48 crore |
| Fresh Issue | ₹214.48 crore |
| Price Band | ₹326 to ₹343 |
| Issue Dates | May 21 to May 25, 2026 |
Category-wise Q-Line Biotec IPO Subscription Status
| Category | Subscription (x) | Shares Offered | Shares Bid For | Total Amount (₹ Cr) | Applications |
| QIB Ex Anchor | 123.94 | 11,88,000 | 14,72,37,200 | 5,050.24 | 197 |
| NII/HNI | 145.92 | 8,91,600 | 13,01,04,400 | 4,462.58 | 49,740 |
| Retail | 70.92 | 20,79,200 | 14,74,53,600 | 5,057.66 | 1,84,317 |
| Total | 102.14 | 41,58,800 | 42,47,95,200 | 14,570.48 | 2,34,254 |
Q-Line Biotec Day’s Wise Subscription Summary
| Date | QIB Ex Anchor | NII | NII > ₹10L | NII < ₹10L | Retail | Total |
| May 21, 2026, Day 1 | 4.15 | 5.26 | 5.85 | 4.08 | 3.71 | 4.17 |
| May 22, 2026, Day 2 | 5.19 | 15.62 | 17.96 | 10.95 | 10.07 | 9.87 |
| May 25, 2026, Day 3 | 123.94 | 145.92 | 178.29 | 81.19 | 70.92 | 102.14 |
Q-Line Biotec IPO Timeline
| Event | Date |
| Issue Open Date | May 21, 2026 |
| Issue Close Date | May 25, 2026 |
| Basis of Allotment Date | May 26, 2026 |
| Initiation of Refunds | May 27, 2026 |
| Credit of Shares | May 27, 2026 |
| Listing Date | May 29, 2026 |
Brief Overview Of The IPO
Q-Line Biotec IPO comprises a fresh issue of ₹214.48 crore. The company has fixed the price band at ₹326 to ₹343 per share, with a lot size of 400 shares.
The company is engaged in developing, manufacturing and marketing reagents, kits, POC devices, consumables and diagnostic equipment for healthcare needs. Q-Line Biotec shares are proposed to list on NSE SME on May 29, 2026.
Source:
- https://www.nseindia.com/market-data/issue-information?symbol=QLINE&series=SME&type=Active
Disclaimer
If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.
Please Note: The information shared is intended solely for informational purposes and does not make any investment recommendations
Join Us
Add as preferred source on Google
